Live attenuated varicella vaccine

被引：66

作者：

Arvin, AM ^{[1
]}

Gershon, AA ^{[1
]}

机构：

[1] COLUMBIA UNIV COLL PHYS & SURG, DEPT PEDIAT, NEW YORK, NY 10032 USA

来源：

ANNUAL REVIEW OF MICROBIOLOGY | 1996年 / 50卷

关键词：

chicken pox; herpes zoster; immunization; shingles; latent virus infection; antiviral therapy;

D O I：

10.1146/annurev.micro.50.1.59

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Varicella-zoster virus (VZV) is a ubiquitous human pathogen that causes varicella, commonly called chicken pox; establishes latency; and reactivates as herpes tester, referred to as shingles. A live attenuated varicella vaccine, derived from the Oka strain of VZV has clinical efficacy for the prevention of varicella. The vaccine induces persistent immunity to VZV in healthy children and adults. Immunization against VZV also has the potential to lower the risk of reactivation of latent virus. The varicella vaccine may eventually reduce or eliminate herpes tester, which is a serious problem for elderly and immunocompromised individuals.

引用

页码：59 / 100

页数：42

共 259 条

[21]

BALFOUR HH, 1988, AM J MED, V85, P68

[22] ACYCLOVIR TREATMENT OF VARICELLA IN OTHERWISE HEALTHY ADOLESCENTS [J].

BALFOUR, HH ;

ROTBART, HA ;

FELDMAN, S ;

DUNKLE, LM ;

FEDER, HM ;

PROBER, CG ;

HAYDEN, GF ;

STEINBERG, S ;

WHITLEY, RJ ;

GOLDBERG, L ;

MCGUIRT, PV .

JOURNAL OF PEDIATRICS, 1992, 120 (04) :627-633

[23] HYPOTHESES ON THE PATHOGENESIS OF HERPES ZOSTER-ASSOCIATED PAIN [J].

BENNETT, GJ .

ANNALS OF NEUROLOGY, 1994, 35 :S38-S41

[24]

BERGEN R E, 1991, Viral Immunology, V4, P151, DOI 10.1089/vim.1991.4.151

[25] THE IMMUNOGENICITY OF THE OKA MERCK VARICELLA VACCINE IN RELATION TO INFECTIOUS VARICELLA-ZOSTER VIRUS AND RELATIVE VIRAL-ANTIGEN CONTENT [J].

BERGEN, RE ;

DIAZ, PS ;

ARVIN, AM .

JOURNAL OF INFECTIOUS DISEASES, 1990, 162 (05) :1049-1054

[26] ENHANCEMENT OF VARICELLA-ZOSTER SPECIFIC IMMUNE-RESPONSES IN THE ELDERLY BY BOOSTING WITH VARICELLA VACCINE [J].

BERGER, R ;

LUESCHER, D ;

JUST, M .

JOURNAL OF INFECTIOUS DISEASES, 1984, 149 (04) :647-647

[27] VALACICLOVIR COMPARED WITH ACYCLOVIR FOR IMPROVED THERAPY FOR HERPES-ZOSTER IN IMMUNOCOMPETENT ADULTS [J].

BEUTNER, KR ;

FRIEDMAN, DJ ;

FORSZPANIAK, C ;

ANDERSEN, PL ;

WOOD, MJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (07) :1546-1553

[28] PHENOTYPIC AND GENOTYPIC CHARACTERIZATION OF ACYCLOVIR-RESISTANT VARICELLA-ZOSTER VIRUSES ISOLATED FROM PERSONS WITH AIDS [J].

BOIVIN, G ;

EDELMAN, CK ;

PEDNEAULT, L ;

TALARICO, CL ;

BIRON, KK ;

BALFOUR, HH .

JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (01) :68-75

[29]

BROYER M, 1985, POSTGRAD MED J, V61, P103

[30]

BRUNELL PA, 1982, LANCET, V2, P1069

← 1 2 3 4 5 6 7 8 9 10 →